Dong Kim, MD
Radiation Oncology · Nashville, TNNPI 1861422420
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $895 of the $1,258 with a category attached, or 71.2%. Accuray Incorporated accounts for 75.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $947 and has fallen 95.2% since, to $45 in 2025.
Across 9 payments — averaging $139.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Accuray Incorporated$947
- Reflexion Medical, Inc.$213
- Beone Medicines USA, Inc.$45
- Beigene USA, Inc.$32
- Johnson & Johnson$21
What the payments were for
- Travel & lodging$36329%
- Food & beverage$89571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Accuray Incorporated | 4 | $947 |
| Reflexion Medical, Inc. | 1 | $213 |
| Beone Medicines USA, Inc. | 2 | $45 |
| Beigene USA, Inc. | 1 | $32 |
| Johnson & Johnson | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,258 in reported general payments places this provider in the 70th percentile of 115 radiation oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 19 | $49,345 |
| Sucralfate | 12 | $1,880 |
| Tamsulosin Hcl | 13 | $298 |
| Nystatin | 15 | $289 |
| Mometasone Furoate | 12 | $271 |
| Dexamethasone | 16 | $211 |
| Lidocaine Hcl ViscousLidocaine Hcl | 15 | $200 |
| Silver Sulfadiazine | 11 | $142 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Nashville
- Han-Chih ChangNashville$66K
- Karen WinkfieldNashville$53K
- James GrayNashville$46K
- John PhillipsNashville$23K
- Casey LipscombNashville$23K
- Andrew KennedyNashville$18K
- Anthony CmelakNashville$16K
- Evan OsmundsonNashville$8K
- Joshua MondscheinNashville$6K
- Diandra Ayala-PeacockNashville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.